Novartis Spain launches 'Lleva la Delantera' breast cancer awareness campaign

Novartis Spain introduced the "Lleva la Delantera" initiative on 18 June in Madrid. The campaign aims to raise awareness of breast cancer, encourage early anticipation of the disease, and provide patients with more information, support and tools to actively participate in health decisions. The event gathered patients, representatives of Spanish cancer organisations – the Federación Española de Cáncer de Mama (FECMA), the Asociación Española de Cáncer de Mama Metastásico (AECMM), the Federació Catalana d’Entitats contra el Càncer (FECEC) and the Asociación Mama Ovario Hereditario (AMOH) – as well as health professionals. Amaya Echevarría, president of Novartis Spain, highlighted the need to ensure that new treatments reach all patients promptly and stressed empowerment through accurate, understandable information. Speakers stressed that each woman's experience is unique and that quality‑of‑life considerations must guide treatment choices, especially in advanced stages.